Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Congenital Adrenal Hyperplasia: early-phase trial registry
4 of 9 indexed Congenital Adrenal Hyperplasia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Congenital Adrenal Hyperplasia: 9 US clinical trials tracked, 4 recruiting.
Congenital Adrenal Hyperplasia is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Crinetics Pharmaceuticals, running 3 of these trials.
Enrollment posture brief
Registry condition congenital-adrenal-hyperplasia
OPEN 4 | RECR 44% | LATE 3 | EARLY 6 | RANK #1916 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)
Congenital Adrenal Hyperplasia lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Congenital Adrenal Hyperplasia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Congenital Adrenal Hyperplasia is recruiting below its size-band peers.
4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Congenital Adrenal Hyperplasia research.
Crinetics Pharmaceuticals accounts for 3 of 9 trials (33.3%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Congenital Adrenal Hyperplasia enrolment sits around 103 participants.
Median target enrolment is 103 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.
-
Congenital Adrenal Hyperplasia research is mostly interventional.
9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Crinetics Pharmaceuticals
NCT07159841
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals
NCT07144163
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
Crinetics Pharmaceuticals
NCT06712823
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
H. Lundbeck A/S
NCT05669950
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia
Neurocrine Biosciences
NCT04490915
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Neurocrine Biosciences
NCT04806451
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Adrenas Therapeutics
NCT04783181
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Neurocrine UK Limited
NCT00519818
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Spruce Biosciences
NCT03687242
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Congenital Adrenal Hyperplasia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Congenital Adrenal Hyperplasia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Congenital Adrenal Hyperplasia page
9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Congenital Adrenal Hyperplasia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Crinetics Pharmaceuticals sponsors the most Congenital Adrenal Hyperplasia trials on record, review their full trial history before evaluating a specific study. See Crinetics Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Congenital Adrenal Hyperplasia condition card totals 9 registered trials; most-linked intervention Placebo; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.